FIELD: medicine; pharmacology.
SUBSTANCE: present invention refers to pharmacology, namely to application of histochrome as an agent possessing antiviral action against tick-borne encephalitis viruses and herpes simplex type I. Histochrome is a high-effective virucidal agent.
EFFECT: what is presented is an agent exhibiting antiviral action against tick-borne encephalitis viruses and herpes simplex type I viruses.
1 cl, 1 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL COMPOSITION | 2018 |
|
RU2697886C1 |
ANTIVIRAL AGENT AGAINST HERPES SIMPLEX VIRUS TYPE 1 | 2022 |
|
RU2782935C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2798102C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2812292C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2809094C1 |
MEANS FOR FORMATION OF MEDICINE FOR CURING TICK-BORNE ENCEPHALITIS | 2016 |
|
RU2651777C1 |
ANTIVIRAL AGENT AGAINST HUMAN HERPESVIRUS TYPE I AND ENTEROVIRUS B | 2022 |
|
RU2798659C1 |
AN ANTIVIRAL AGENT AGAINST SARS-COV-2 CORONAVIRUS | 2022 |
|
RU2788762C1 |
CYTOTOXIC AND ANTIVIRAL ACTIVITY OF 3-ACYLOXYMETHYL-3-OXO-1-CYANO-2,3-SECO-2-NOR-TRITERPENOIDS | 2018 |
|
RU2686100C1 |
CYTOTOXIC AND ANTI-VIRAL ACTIVITY OF 3-ACYLOXIMETHYL-3-OXO-1-CYANO-2,3-SECO-2-NOR-TRITERPENOIDES | 2018 |
|
RU2682669C1 |
Authors
Dates
2019-08-21—Published
2018-08-06—Filed